From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease".

Saved in:
Bibliographic Details
Title: From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson's disease. Scientific commentary on: "Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease".
Authors: Shebl N; Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt., Salama M; Institute of Global Health and Human Ecology, The American University in Cairo, Cairo, Egypt. Mohamed-Salama@aucegypt.edu.; Global Brain Health Institute (GBHI), Trinity College Dublin, Dublin 2, Ireland. Mohamed-Salama@aucegypt.edu.; Faculty of Medicine, Mansoura University, El Mansûra, Egypt. Mohamed-Salama@aucegypt.edu.
Source: Acta neuropathologica [Acta Neuropathol] 2024 May 18; Vol. 147 (1), pp. 88. Date of Electronic Publication: 2024 May 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-0533
DOI:10.1007/s00401-024-02739-5